Clinical Trials Logo

Clinical Trial Summary

The purpose of the Amplatzer PFO Occluder post-marketing clinical use surveillance study is to observe the frequency, type and degree of adverse device effects and adverse events in order to assure the safety of the new medical device, and to collect safety and efficacy information for evaluating the results of the clinical use.


Clinical Trial Description

Based on the Ministerial Ordinance on Good Post-marketing Study Practice for Medical Device, the Surveillance will register patients with patent foramen ovale (PFO) who have experienced a PFO-related cryptogenic cerebral infarction (including diagnosed paradoxical cerebral embolism) or transient ischemic attack (determined by positive head imaging such as DWI) in whom an Amplatzer PFO Occluder implant was attempted (Marketing Approval No. 30100BZX00024000, date May 28, 2019, hereinafter referred to as "PFO occluder"). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04349995
Study type Observational
Source Abbott Medical Devices
Contact
Status Active, not recruiting
Phase
Start date October 1, 2019
Completion date May 28, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT04433520 - Trevisio Post-Approval Study
Recruiting NCT05529901 - Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder
Active, not recruiting NCT04029233 - The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO
Recruiting NCT06046508 - Migraine With Aura and Patent Foramen Ovale: Identification of Biomarkers to Select Patients In Whom Intervention Would Be Beneficial (MANET)
Recruiting NCT03821129 - GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study N/A
Not yet recruiting NCT06203873 - A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine N/A
Recruiting NCT06033937 - COMPETE Cohort Study
Active, not recruiting NCT04100135 - GORE® CARDIOFORM Septal Occluder Migraine Clinical Study N/A
Recruiting NCT04946734 - Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine Phase 3